New drug MTX325 enters first human tests for Parkinson's
Disease control
Recruiting now
This early-stage study tests a new drug called MTX325 in healthy volunteers and people with mild to moderate Parkinson's disease. The main goals are to check safety, how the body processes the drug, and whether it reaches the brain. If successful, MTX325 might one day slow the pr…
Phase: PHASE1 • Sponsor: Mission Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC